Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Low physical performance determined by chair rising test muscle mechanography is associated with prevalent fragility fractures.

Rupp T, Butscheidt S, Jähn K, Simon MJ, Mussawy H, Oheim R, Barvencik F, Amling M, Rolvien T.

Arch Osteoporos. 2018 Jul 2;13(1):71. doi: 10.1007/s11657-018-0490-0.

PMID:
29968169
2.

Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2.

Butscheidt S, Delsmann A, Rolvien T, Barvencik F, Al-Bughaili M, Mundlos S, Schinke T, Amling M, Kornak U, Oheim R.

Osteoporos Int. 2018 Jul;29(7):1643-1651. doi: 10.1007/s00198-018-4499-4. Epub 2018 Mar 29.

PMID:
29594386
3.

Disease Duration and Stage Influence Bone Microstructure in Patients With Primary Biliary Cholangitis.

Schmidt T, Schmidt C, Schmidt FN, Butscheidt S, Mussawy H, Hubert J, Hawellek T, Oehler N, Barvencik F, Lohse AW, Schinke T, Schramm C, Amling M, Rolvien T.

J Bone Miner Res. 2018 Jun;33(6):1011-1019. doi: 10.1002/jbmr.3410. Epub 2018 Mar 25.

PMID:
29470841
4.

A retrospective analysis of bone mineral status in patients requiring spinal surgery.

Schmidt T, Ebert K, Rolvien T, Oehler N, Lohmann J, Papavero L, Kothe R, Amling M, Barvencik F, Mussawy H.

BMC Musculoskelet Disord. 2018 Feb 13;19(1):53. doi: 10.1186/s12891-018-1970-5.

5.

Correction: Vitamin-D-Stoffwechsel des Knochens.

Barvencik F, Amling M.

Orthopade. 2018 Jan;47(1):66. doi: 10.1007/s00132-017-3499-y. German. No abstract available.

PMID:
29046926
6.

Denosumab in bone marrow oedema syndrome. Response to Letter to the Editor of Injury.

Rolvien T, Schmidt T, Barvencik F, Amling M.

Injury. 2017 Oct;48(10):2368. doi: 10.1016/j.injury.2017.07.029. Epub 2017 Jul 31. No abstract available.

PMID:
28784253
7.

ß-TCP bone substitutes in tibial plateau depression fractures.

Rolvien T, Barvencik F, Klatte TO, Busse B, Hahn M, Rueger JM, Rupprecht M.

Knee. 2017 Oct;24(5):1138-1145. doi: 10.1016/j.knee.2017.06.010. Epub 2017 Jul 13.

PMID:
28712710
8.

Severe bone loss and multiple fractures in SCN8A-related epileptic encephalopathy.

Rolvien T, Butscheidt S, Jeschke A, Neu A, Denecke J, Kubisch C, Meisler MH, Pueschel K, Barvencik F, Yorgan T, Oheim R, Schinke T, Amling M.

Bone. 2017 Oct;103:136-143. doi: 10.1016/j.bone.2017.06.025. Epub 2017 Jul 1.

PMID:
28676440
9.

Clinical, radiographic and biochemical characteristics of adult hypophosphatasia.

Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, Rüther W, Amling M, Barvencik F.

Osteoporos Int. 2017 Sep;28(9):2653-2662. doi: 10.1007/s00198-017-4087-z. Epub 2017 May 25.

PMID:
28547134
10.

Denosumab and surgery for the treatment of Perthes' disease in a 9-year-old boy: favorable course documented by comprehensive imaging- a case report.

Meiss AL, Barvencik F, Babin K, Eggers-Stroeder G.

Acta Orthop. 2017 Jun;88(3):354-357. doi: 10.1080/17453674.2017.1298020. Epub 2017 Mar 14. No abstract available.

11.

Denosumab is effective in the treatment of bone marrow oedema syndrome.

Rolvien T, Schmidt T, Butscheidt S, Amling M, Barvencik F.

Injury. 2017 Apr;48(4):874-879. doi: 10.1016/j.injury.2017.02.020. Epub 2017 Feb 22.

PMID:
28242067
12.

Sheep model for osteoporosis: The effects of peripheral hormone therapy on centrally induced systemic bone loss in an osteoporotic sheep model.

Oheim R, Simon MJK, Steiner M, Vettorazzi E, Barvencik F, Ignatius A, Amling M, Clarke IJ, Pogoda P, Beil FT.

Injury. 2017 Apr;48(4):841-848. doi: 10.1016/j.injury.2017.02.009. Epub 2017 Feb 20.

PMID:
28237183
13.

[Impact of Vitamin D in Sports: Does Vitamin D Insufficiency Compromise Athletic Performance?]

Butscheidt S, Rolvien T, Ueblacker P, Amling M, Barvencik F.

Sportverletz Sportschaden. 2017 Jan;31(1):37-44. doi: 10.1055/s-0042-121748. Epub 2017 Feb 20. Review. German.

PMID:
28219093
14.

[Hypophosphatasia : What is currently available for treatment?]

Schmidt T, Amling M, Barvencik F.

Internist (Berl). 2016 Dec;57(12):1145-1154. doi: 10.1007/s00108-016-0147-2. Review. German.

PMID:
27796472
15.

[Medication and bone metabolism: Clinical importance for fracture treatment].

Barvencik F.

Unfallchirurg. 2015 Dec;118(12):1017-24. doi: 10.1007/s00113-015-0109-5. Review. German.

PMID:
26573290
16.

Economic evaluation of vitamin D and calcium food fortification for fracture prevention in Germany.

Sandmann A, Amling M, Barvencik F, König HH, Bleibler F.

Public Health Nutr. 2017 Jul;20(10):1874-1883. doi: 10.1017/S1368980015003171. Epub 2015 Nov 16.

PMID:
26568196
17.

[Vitamin D metabolism of the bone].

Barvencik F, Amling M.

Orthopade. 2015 Sep;44(9):686-694. doi: 10.1007/s00132-015-3135-7. German. Erratum in: Orthopade. 2018 Jan;47(1):66.

PMID:
26201944
18.

[Calcium and vitamin D in osteology].

Amling M, Barvencik F.

Z Rheumatol. 2015 Jun;74(5):421-32; quiz 433-4. doi: 10.1007/s00393-014-1510-0. German.

PMID:
26085074
19.

Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.

Krause M, Keller J, Beil B, van Driel I, Zustin J, Barvencik F, Schinke T, Amling M.

Osteoporos Int. 2015 Mar;26(3):987-95. doi: 10.1007/s00198-014-2965-1. Epub 2014 Nov 13.

PMID:
25391248
20.

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts.

Keller J, Catala-Lehnen P, Huebner AK, Jeschke A, Heckt T, Lueth A, Krause M, Koehne T, Albers J, Schulze J, Schilling S, Haberland M, Denninger H, Neven M, Hermans-Borgmeyer I, Streichert T, Breer S, Barvencik F, Levkau B, Rathkolb B, Wolf E, Calzada-Wack J, Neff F, Gailus-Durner V, Fuchs H, de Angelis MH, Klutmann S, Tsourdi E, Hofbauer LC, Kleuser B, Chun J, Schinke T, Amling M.

Nat Commun. 2014 Oct 21;5:5215. doi: 10.1038/ncomms6215.

Supplemental Content

Loading ...
Support Center